Physician profile
Ardaman S Nanda
NPI 1215994892
$1,218.95
in general payments reported to CMS, 2019-2025
14 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.25 · 2020: $17.90 · 2021: $120 · 2022: $22.03 · 2023: $244 · 2024: $341 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $293.38 | 2019-2025 | Lifevest |
| Pfizer INC. | $195.28 | 2024-2025 | |
| Boston Scientific Corporation | $151.16 | 2021-2025 | Rotablator Rotational Atherectomy System Console Kit, Avvigo Guidance System, Emerge Push |
| Abbott Laboratories | $121.92 | 2021-2025 | Aveir |
| Shockwave Medical, INC | $97.43 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $69.19 | 2024 | Impella |
| Medtronic Vascular, INC. | $66.80 | 2019-2020 | |
| Medtronic, INC. | $63.06 | 2021-2025 | Onyx Frontier, Linq II |
| Amgen INC. | $50.59 | 2024-2025 | Repatha, Repatha |
| Cvrx, INC. | $42.39 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $25.82 | 2021 | |
| Novo Nordisk INC | $19.60 | 2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $15.44 | 2024 | Eliquis |
| Cardiovascular Systems INC. | $6.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ardaman Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.